We are live on ! Find out more
EFTRW

eFFECTOR Therapeutics, Inc. Warrant
EFTRW

Delisted

EFTRW was delisted on the 2nd of July, 2024.

Back to rankings

21 hedge funds and large institutions have $5.66M invested in eFFECTOR Therapeutics, Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

8% more capital invested

Capital invested by funds: $5.23M → $5.66M (+$427K)

45% less funds holding

Funds holding: 38 → 21 (-17)

59% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 29

Holders
21
Holders Change
-17
Holders Change %
-44.74%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
4
Reduced
1
Closed
29
Calls
$737K
Puts
–
Net Calls
+$737K
Net Calls Change
+$443K

Top Buyers

Rank Fund Capital Flow
1
AC
Aristeia Capital
Connecticut
+$1.78M
2
Goldman Sachs
Goldman Sachs
New York
+$616K
3
CS
Credit Suisse
Switzerland
+$182K
4
WAM
Wolverine Asset Management
Illinois
+$68.4K
5
AGM
Alpine Global Management
New York
+$49.1K

Top Sellers

Rank Fund Capital Flow
1
RCM
Radcliffe Capital Management
Pennsylvania
-$1.27M
2
AFM
Anson Funds Management
Texas
-$1.08M
3
LA
Linden Advisors
New York
-$316K
4
Citadel Advisors
Citadel Advisors
Florida
-$201K
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$200K
Name Holding Trade Value Shares
Change 		Change in
Stake
GCL
26
Glazer Capital LLC
New York
– -$164K -164,259 Closed
PC
27
Periscope Capital
Ontario, Canada
– -$142K -141,400 Closed
RCM
28
Radcliffe Capital Management
Pennsylvania
– -$1.27M -128,247 Closed
AFM
29
Anson Funds Management
Texas
– -$1.08M -109,430 Closed
SC
30
Sculptor Capital
New York
– -$108K -104,166 Closed
LP
31
LMR Partners
United Kingdom
– -$100K -100,000 Closed
FTCM
32
Fir Tree Capital Management
New York
– -$100K -99,998 Closed
WP
33
Woodline Partners
California
– -$94K -93,922 Closed
PSAMP
34
P. Schoenfeld Asset Management (PSAM)
New York
– -$67K -66,666 Closed
SCC
35
Spring Creek Capital
Kansas
– -$67K -66,666 Closed
ACA
36
Arena Capital Advisors
California
– -$63K -62,690 Closed
AA
37
AQR Arbitrage
Connecticut
– -$45K -44,998 Closed
PMAM
38
Picton Mahoney Asset Management
Ontario, Canada
– -$33K -33,332 Closed
ACM
39
Atalaya Capital Management
New York
– -$33K -32,597 Closed
EAM
40
Exos Asset Management
New York
– -$22K -21,933 Closed
BI
41
Bulldog Investors
New Jersey
– -$20K -19,566 Closed
HIM
42
HGC Investment Management
Ontario, Canada
– -$17K -16,666 Closed
PI
43
PEAK6 Investments
Illinois
– -$17K -16,666 Closed
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
– -$15K -14,945 Closed
PCM
45
Prelude Capital Management
New York
– -$12K -12,055 Closed
BFM
46
Boothbay Fund Management
New York
– -$117K -11,814 Closed
Walleye Capital
47
Walleye Capital
New York
– -$10 -10,000 Closed
CAPTRUST Financial Advisors
48
CAPTRUST Financial Advisors
North Carolina
– -$5K -4,651 Closed
SCM
49
Segantii Capital Management
Hong Kong
– -$38K -3,886 Closed
TRCT
50
Tower Research Capital (TRC)
New York
– +$28 +23 New
1
2

EFTRW Hedge Fund Activity: Q3 2021 in Review

21 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Warrant (EFTRW) for Q3 2021, worth a combined $5.66M — up 8.2% from $5.23M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of EFTRW and 12 opened new positions — a net loss of 17 holders — while 1 trimmed existing stakes and 4 added.

The largest buyer was Aristeia Capital, adding an estimated $1.78M. The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $1.27M sold.

  • 21 institutional investors held eFFECTOR Therapeutics, Inc. Warrant (EFTRW) as of Q3 2021, down from 38 in Q2 2021.
  • Funds reported $5.66M of eFFECTOR Therapeutics, Inc. Warrant stock for Q3 2021, up 8.2% quarter-over-quarter.
  • 12 funds opened new eFFECTOR Therapeutics, Inc. Warrant positions in Q3 2021 and 29 closed out, a net change of -17 holders.
  • The largest eFFECTOR Therapeutics, Inc. Warrant buyer in Q3 2021 was Aristeia Capital, an estimated $1.78M added.
  • The largest eFFECTOR Therapeutics, Inc. Warrant seller in Q3 2021 was Radcliffe Capital Management, an estimated $1.27M sold.

Based on aggregated 13F filings for Q3 2021.